Source link : https://newshealth.biz/health-news/targeted-duo-wins-again-in-braf-mutant-colorectal-cancer/
(MedPage Today) — SAN FRANCISCO — Including encorafenib (Braftovi) and cetuximab (Erbitux) in the first-line treatment of BRAF V600E-mutated metastatic colorectal cancer led to a significant improvement in overall response rate (ORR), according… Source link : https://www.medpagetoday.com/meetingcoverage/ascogi/119298 Author : Publish date : 2026-01-06 19:27:00 Copyright for syndicated content belongs to the linked Source.
The post Targeted Duo Wins Again in BRAF-Mutant Colorectal Cancer first appeared on News Health.
—-
Author : News Health
Publish date : 2026-01-06 19:27:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8